CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of innovative Active Pharmaceutical Ingredients (APIs), Lipid Excipients, and Drug Products, has joined the Science Based Targets initiative (SBTi) to actively drive down global emissions across the company.   In line with the Paris Agreement’s aims to limit the global warming temperature increase to 1.5 °C, halve emissions before 2030 and achieve Net Zero by 2050, CordenPharma has announced that it will evalua...